XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Revenues        
Revenues $ 2,167 $ 1,967 $ 4,111 $ 3,885
Expenses        
Selling, general and administrative 711 676 1,436 1,298
Research and development 156 127 299 254
Amortization of intangible assets 269 302 542 612
Goodwill impairments 0 83 0 83
Asset impairments 37 6 50 14
Restructuring, integration, separation and IPO costs 16 35 26 48
Other (income) expense, net (83) 0 (60) 2
Total expenses 1,755 1,806 3,524 3,439
Operating income 412 161 587 446
Interest income 7 3 13 5
Interest expense (319) (410) (626) (772)
Gain on extinguishment of debt 0 113 0 113
Foreign exchange and other (21) 4 (31) (3)
Income (loss) before income taxes 79 (129) (57) (211)
(Provision for) benefit from income taxes (52) (10) (125) 6
Net income (loss) 27 (139) (182) (205)
Net (income) loss attributable to noncontrolling interest (1) (6) 7 (9)
Net income (loss) attributable to Bausch Health Companies Inc. $ 26 $ (145) $ (175) $ (214)
Earnings (loss) per share attributable to Bausch Health Companies Inc.        
Basic (in usd per share) $ 0.07 $ (0.40) $ (0.48) $ (0.59)
Diluted (in usd per share) $ 0.07 $ (0.40) $ (0.48) $ (0.59)
Weighted-average common shares        
Basic (in shares) 364.8 362.2 364.1 361.5
Diluted (in shares) 367.1 362.2 364.1 361.5
Product sales        
Revenues        
Revenues $ 2,146 $ 1,944 $ 4,068 $ 3,835
Expenses        
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 640 568 1,212 1,104
Other revenues        
Revenues        
Revenues 21 23 43 50
Expenses        
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues $ 9 $ 9 $ 19 $ 24